Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Non-cash Items: 2017-2025

Historic Non-cash Items for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $3.1 million.

  • Puma Biotechnology's Non-cash Items fell 19.16% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 19.16%. This contributed to the annual value of $3.6 million for FY2024, which is 227.72% up from last year.
  • As of Q3 2025, Puma Biotechnology's Non-cash Items stood at $3.1 million, which was up 333.57% from $726,000 recorded in Q2 2025.
  • Puma Biotechnology's Non-cash Items' 5-year high stood at $4.3 million during Q1 2021, with a 5-year trough of $145,000 in Q3 2023.
  • Moreover, its 3-year median value for Non-cash Items was $726,000 (2025), whereas its average is $1.7 million.
  • As far as peak fluctuations go, Puma Biotechnology's Non-cash Items crashed by 95.96% in 2023, and later spiked by 2,585.50% in 2024.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Non-cash Items stood at $3.8 million in 2021, then fell by 5.77% to $1.0 million in 2022, then grew by 5.64% to $1.1 million in 2023, then slumped by 71.67% to $313,000 in 2024, then dropped by 19.16% to $3.1 million in 2025.
  • Its Non-cash Items was $3.1 million in Q3 2025, compared to $726,000 in Q2 2025 and $355,000 in Q1 2025.